Laboratoire Negma SAS (Negma) is a leading pharmaceutical company based in France. The company has presence across the value the pharmaceutical value chain that ranges from research and development; API manufacturing, to manufacturing, conditioning and packaging of final products, as well as the promotion. It develops products pertaining to areas such as Osteoarthritis/Rheumatology, Arterial Hypertension and CHF; Phlebotonic/Vasculoprotector and others. The company`s patent portfolio consists of 172 international patents rights. It has two manufacturing facilities located in Quimper and Nevers. The products manufactured by the company are sold to wholesales and distributors through an in-house promotion network of 230 medical representatives covering an entire French territory. NEGMA is a subsidiary of Wockhardt Limited. The company is headquartered in Paris, France.

Street: 
10 rue Paul Dautier
City: 
Velizy
Postcode: 
78141
Federal State : 
France
WebSite: 
www.wockhardtin.com
Fax: 
33-1-39258070

Company Index Score

Current Index Score Historical Index Score
  • Laboratoire Negma SAS currently scores 50 % in the index.
  • Laboratoire Negma SAS is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Laboratoire Negma SAS is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets